Surgery News

Patients with aortic stenosis who were at low risk and underwent transcatheter aortic valve replacement had similar short-term and midterm survival rates compared with those who underwent surgical AVR, according to a study published in JAMA Network Open.

Researchers assessed the safety and efficacy of a bioprosthetic valve with novel tissue (Resilia, Edwards Lifesciences) in patients undergoing surgical aortic valve replacement.

Patients who underwent transcatheter aortic valve replacement or surgical AVR had an increased risk for new-onset atrial fibrillation, according to a study published in JAMA Internal Medicine.

The FDA has designated Edwards Lifesciences’ product recall of an intra-aortic occlusion device as a class 1 recall, the most serious kind. The recall affects 757 devices distributed between May 1, 2017, and Feb. 19, 2019.

In-hospital stroke is rare after elective endovascular aortic aneurysm repair, but it is more common after complex EVAR and thoracic endovascular aortic repair, researchers reported at the Society for Vascular Surgery Vascular Annual Meeting.

Longitudinal risk was predicted by a scoring system that assessed anatomical complexity in patients undergoing revascularization, according to a study published in JAMA Cardiology.

The CMS recently eliminated the requirement that patients with aortic stenosis be evaluated by two cardiac surgeons before undergoing transcatheter aortic valve replacement to help speed up and optimize the decision-making process, but other regulatory barriers to optimal care for these patients remain, according to a viewpoint published in JAMA Cardiology.

Three in 10 vascular surgeons met criteria for burnout and more than one-third said they had symptoms of depression, according to the results of a survey presented at the Society for Vascular Surgery Vascular Annual Meeting.

More than 40% of vascular surgeons said they have experienced sexual harassment in the workplace, according to the results of a survey presented at the Society for Vascular Surgery Vascular Annual Meeting.

In two real-world studies presented at the Society for Vascular Surgery Vascular Annual Meeting, transcarotid artery revascularization was associated with low rates of stroke, death and other clinical outcomes.